Marex Group plc

Position in MRNA — Moderna, Inc.

CIK 1997464 London, X0

Position in MRNA

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$3,231,997

+$2,391,002 QoQ

Shares Held

63,622

+123.1% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Marex Group plc holds $67,081,190 across 58 Biotechnology names. MRNA ranks #7 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SANA	Sana Biotechnology, Inc.	3,999,100	$11,517,408
2	TGTX	Tg Therapeutics, Inc.	278,343	$9,246,553
3	NTLA	Intellia Therapeutics, Inc.	623,600	$7,994,552
4	CRSP	CRISPR Therapeutics AG	134,097	$6,378,994
5	DNLI	Denali Therapeutics Inc.	287,000	$5,510,400
6	VRTX	Vertex Pharmaceuticals Inc / Ma	7,368	$3,290,106
7	MRNA	Moderna, Inc. This page	63,622	$3,231,997
8	REGN	Regeneron Pharmaceuticals, Inc.	1,739	$1,343,620

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,231,997	63,622	+123.1%	Shares	Defined	2026-05-13
2025-12-31	$840,995	28,518	-87.9%	Shares	Defined	2026-02-12
2025-09-30	$6,105,049	236,355	+1718.3%	Shares	Defined	2025-11-14
2025-06-30	$358,642	12,999	-90.0%	Shares	Defined	2025-08-19
2025-03-31	$3,682,664	129,900	+49.5%	Shares	Defined	2026-04-02
2024-12-31	$3,613,301	86,900	+351.1%	Shares	Defined	2026-04-02
2024-09-30	$1,287,479	19,265	+25.5%	Shares	Defined	2026-04-07
2024-06-30	$1,822,218	15,345	-7.5%	Shares	Defined	2026-04-02
2024-03-31	$1,768,363	16,595	+16.1%	Shares	Defined	2026-04-02
2023-12-31	$1,421,140	14,290	+68.8%	Shares	Defined	2026-04-02
2023-09-30	$874,349	8,465	+29.5%	Shares	Defined	2026-04-02
2023-03-31	$1,003,645	6,535	-75.8%	Shares	Defined	2026-04-02
2022-12-31	$4,847,225	26,986	—	Shares	Defined	2026-04-02
No filing history on record for this holder in this stock.